Athira Pharma (ATHA) Investigation
Did you invest in Athira Pharma fka M3 Biotechnology and are concerned you suffered losses?
Investor rights attorneys at the Goldman Scarlaot & Penny law firm are preparing to take action an seek compensation on behalf of Athira investors - both who invested in Athira's 2020 IPO and those who invested in Athira Pharma's private placements.
The GSP attorneys Alan Rosca and Paul Scarlato have been investigating the circumstances related to the Athira securities offering and have identified areas of concern. Athira investors, who would like to learn more about our investigation or who have any useful information may contact attorney Rosca and his colleagues by calling 888-998-0530, via email at rosca@lawgsp.com or through the contact form on Athira Pharma Investor Center page.

Comments
Post a Comment